Vivo Capital, LLC

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed August 14, 2024), Vivo Capital, LLC reported 42 stock positions worth $1.1 billion. Its top holding was Soleno Therapeutics (SLNO) at 27.6% of the portfolio, followed by Geron (GERN, 10.7%) and Harmony Biosciences (HRMY, 7.3%). Compared with Q1 2024, it opened 4 new positions, sold out of 4, added to 2 and reduced 5. The biggest buy was a new position in Erasca (ERAS) and the biggest sale an exit from Alpine Immune Sciences (ALPN).

Most Recent 13F
Q2 2026
Location
Palo Alto, CA
CIK
0001674712
Portfolio Value
$1.1B (Q2 2024)
SEC Filing
0001213900-24-068546 ↗ filed Aug 14, 2024

Holdings Value

0$500.0M$1.0B$1.5B$2.0B Q1 2024: $1.3B Q1 2024 Q2 2024: $1.1B $1.1B Q2 2024 Q3 2024: $1.2B Q3 2024 Q4 2024: $892.6M Q4 2024 Q1 2025: $755.1M Q1 2025 Q2 2025: $977.1M Q2 2025 Q3 2025: $1.2B Q3 2025 Q4 2025: $1.5B Q4 2025 Q1 2026: $1.2B Q1 2026 Q2 2026: $1.1B Q2 2026

Holdings 42 stocks · $1.1B

SLNO Soleno Therapeutics Inc. 27.58% 7,316,851 $298.5M Reduce -13.1%
GERN Geron Corp. 10.66% 27,225,292 $115.4M No change
HRMY Harmony Biosciences Holdings 7.26% 2,606,247 $78.6M No change
SVA Sinovac Biotech Ltd. 7.05% 11,800,000 $76.3M No change
DYN Dyne Therapeutics Inc. 5.33% 1,635,136 $57.7M No change
AVDL Avadel Pharmaceuticals plc 5.16% 3,972,099 $55.8M No change
VRNA Verona Pharma Ltd. 4.74% 3,549,758 $51.3M Reduce -1.7%
TERN Terns Pharmaceuticals Inc. 3.89% 6,182,992 $42.1M Reduce -7.1%
ALXO Alx Oncology Holdings Inc. 2.35% 4,220,048 $25.4M No change
VRDN Viridian Therapeutics Inc. 2.02% 1,678,207 $21.8M No change
ATXS Astria Therapeutics Inc. 1.96% 2,329,027 $21.2M No change
SLN Silence Therapeutics PLC-ADR 1.94% 1,105,454 $21.0M No change
OLMA Olema Pharmaceuticals Inc. 1.87% 1,873,704 $20.3M No change
COGT Cogent Biosciences Inc. 1.75% 2,244,941 $18.9M No change
ERAS Erasca Inc. 1.47% 6,756,756 $15.9M New
TARS Tarsus Pharmaceuticals Inc. 1.42% 565,550 $15.4M No change
DCTH Delcath Systems Inc. 1.29% 1,666,746 $14.0M No change
RZLT Rezolute Inc. 1.11% 2,797,704 $12.0M No change
CELC Celcuity Inc. 0.92% 610,500 $10.0M New
SERA Sera Prognostics Inc. Class A 0.90% 1,650,440 $9.8M No change
CMPS Compass Pathways PLC 0.90% 1,608,000 $9.7M No change
ZLAB Zai Lab Ltd.-ADR 0.85% 531,198 $9.2M No change
ORIC Oric Pharmaceuticals Inc. 0.83% 1,269,676 $9.0M Add +49.4%
RGLS Regulus Therapeutics Inc. 0.82% 5,000,000 $8.9M No change
ABEO Abeona Therapeutics Inc. 0.72% 1,842,751 $7.8M New
TRML Tourmaline Bio Inc. 0.70% 591,882 $7.6M No change
CRBP Corbus Pharmaceuticals Holdi 0.70% 166,794 $7.5M New
IOBTQ Io Biotech Inc. 0.67% 6,173,439 $7.2M No change
TIL Instil Bio Inc. 0.59% 624,339 $6.4M Add +0.0%
ENGN Engene Holdings Inc. 0.59% 678,705 $6.4M No change
VSTM Verastem Inc. 0.42% 1,538,461 $4.6M No change
CMPX Compass Therapeutics Inc. 0.33% 3,556,023 $3.6M No change
ALLK Allakos LLC 0.28% 2,988,000 $3.0M No change
BOLT Bolt Biotherapeutics Inc. 0.24% 3,521,291 $2.6M No change
UNICYCIVE THERAPEUTICS INC 0.16% 3,470,152 $1.7M No change
ALGS Aligos Therapeutics Inc. 0.11% 3,547,030 $1.2M No change
CDXS Codexis Inc. 0.11% 388,144 $1.2M No change
DBV TECHNOLOGIES S A 0.10% 1,354,437 $1.1M No change
ADVM Adverum Biotechnologies Inc. 0.08% 833,333 $833K Reduce -44.4%
WHWK Whitehawk Therapeutics Inc. filed as AADI BIOSCIENCE INC 0.07% 509,572 $744K No change
QTTB Q32 Bio Inc. 0.03% 20,559 $369K Reduce -94.4%
DTIL Precision Biosciences Inc. 0.00% 4,675 $45K No change

Portfolio Sells Q1 2024 → Q2 2024

ALPN Alpine Immune Sciences Inc. Sold out 0.00% −1.63
ADVM Adverum Biotechnologies Inc. Reduce -44.4% 0.08% −1.59
CRNX Crinetics Pharmaceuticals Inc. Sold out 0.00% −1.29
GTH Genetron Holdings Ltd.-ADR Sold out 0.00% −0.86
SVRA Savara Inc. Sold out 0.00% −0.82
SLNO Soleno Therapeutics Inc. Reduce -13.1% 27.58% −0.74
QTTB Q32 Bio Inc. Reduce -94.4% 0.03% −0.46
VRNA Verona Pharma Ltd. Reduce -1.7% 4.74% +0.18
TERN Terns Pharmaceuticals Inc. Reduce -7.1% 3.89% +0.46

Portfolio Buys Q1 2024 → Q2 2024

ERAS Erasca Inc. New 1.47% +1.47
CELC Celcuity Inc. New 0.92% +0.92
ABEO Abeona Therapeutics Inc. New 0.72% +0.72
CRBP Corbus Pharmaceuticals Holdi New 0.70% +0.70
TIL Instil Bio Inc. Add +0.0% 0.59% +0.06
ORIC Oric Pharmaceuticals Inc. Add +49.4% 0.83% −0.09

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 47$1.1BTRVI, PRAX, ERAS, AVBP, ABVX
Q1 2026Amended 46$1.2BERAS, PRAX, TERN, TRVI, DBVT
Q4 2025 47$1.5BTERN, CDTX, PRAX, COGT, TRVI
Q3 2025 47$1.2BSLNO, VRNA, CDTX, TERN, TRVI
Q2 2025 42$977.1MSLNO, VRNA, CDTX, GERN, SVA
Q1 2025 40$755.1MSLNO, VRNA, GERN, TRVI, AVDL
Q4 2024 40$892.6MSLNO, VRNA, GERN, TERN, AVDL
Q3 2024 43$1.2BSLNO, GERN, HRMY, VRNA, SVA
Q2 2024 42$1.1BSLNO, GERN, HRMY, SVA, DYN
Q1 2024 42$1.3BSLNO, GERN, HRMY, SVA, AVDL